These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 19262080)
21. Do we have to rethink serologic markers used to diagnose hepatitis B infection? Roeckel IE Ann Clin Lab Sci; 1989; 19(6):397-400. PubMed ID: 2604376 [TBL] [Abstract][Full Text] [Related]
22. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of occult hepatitis B infection in tissue donors: a multicenter analysis in Spain. Sánchez Ibáñez J; Vilarrodona Serrat A; Seoane Pillado T; Rodriguez Aierbe C; Villalba Montoro R; Calvo Benito J; Pevida Lopez M; Fernández Paneque S; Vuelta Lopez E; Martínez Lorenzo MJ; González Romero M; Cañizares Castellanos A; Sauleda Oliveras S Cell Tissue Bank; 2019 Dec; 20(4):513-526. PubMed ID: 31451994 [TBL] [Abstract][Full Text] [Related]
24. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg]. Ren F; Li H; Zhao H Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742 [TBL] [Abstract][Full Text] [Related]
25. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Dreier J; Kröger M; Diekmann J; Götting C; Kleesiek K Transfus Med; 2004 Apr; 14(2):97-103. PubMed ID: 15113374 [TBL] [Abstract][Full Text] [Related]
26. [Antibodies against hepatitis B virus core antigen among blood donors]. Moncharmont P; Bourgeot C; Papon S; Duraffourg M Transfus Clin Biol; 2000 Feb; 7(1):63-9. PubMed ID: 10730347 [TBL] [Abstract][Full Text] [Related]
27. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor. Almeida RP; Cardoso DD J Clin Virol; 2006 Jul; 36(3):231-4. PubMed ID: 16574475 [TBL] [Abstract][Full Text] [Related]
28. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc. Kang SY; Kim MH; Lee WI Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720 [TBL] [Abstract][Full Text] [Related]
29. Comparison of hepatitis B, core, HBc, and hepatitis B antibody, anti HBs, in a presumed low risk donor population. Heck E; Cavanagh HD Cell Tissue Bank; 2014 Sep; 15(3):435-7. PubMed ID: 24374389 [TBL] [Abstract][Full Text] [Related]
30. The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea. Kang SY; Kim MH; Lee WI J Med Virol; 2010 Sep; 82(9):1508-14. PubMed ID: 20648604 [TBL] [Abstract][Full Text] [Related]
31. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713 [TBL] [Abstract][Full Text] [Related]
32. Risk factors and anti-HBc reactivity among first time blood donors. Molijn MH; van der Linden JM; Ko LK; Gorgels J; Hop W; van Rhenen DJ Vox Sang; 1997; 72(4):207-10. PubMed ID: 9228709 [TBL] [Abstract][Full Text] [Related]
33. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. Silva CM; Costi C; Costa C; Michelon C; Oravec R; Ramos AB; Niel C; Rossetti ML J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity. Salawu L; Adegoke AO; Aboderin AO; Huraina HA West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836 [TBL] [Abstract][Full Text] [Related]
35. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098 [TBL] [Abstract][Full Text] [Related]
36. Anti-HBc screening in Indian blood donors: still an unresolved issue. Dhawan HK; Marwaha N; Sharma RR; Chawla Y; Thakral B; Saluja K; Sharma SK; Thakur MK; Jain A World J Gastroenterol; 2008 Sep; 14(34):5327-30. PubMed ID: 18785287 [TBL] [Abstract][Full Text] [Related]
37. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B]. Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469 [TBL] [Abstract][Full Text] [Related]
38. Safety of anti-hepatitis B core antibody-positive donors for living-donor liver transplantation. Hwang S; Moon DB; Lee SG; Park KM; Kim KH; Ahn CS; Lee YJ; Chu CW; Yang HS; Cho SH; Oh KB; Ha TY; Min PC Transplantation; 2003 Feb; 75(3 Suppl):S45-8. PubMed ID: 12589140 [TBL] [Abstract][Full Text] [Related]
39. Infectivity of blood products from donors with occult hepatitis B virus infection. Allain JP; Mihaljevic I; Gonzalez-Fraile MI; Gubbe K; Holm-Harritshøj L; Garcia JM; Brojer E; Erikstrup C; Saniewski M; Wernish L; Bianco L; Ullum H; Candotti D; Lelie N; Gerlich WH; Chudy M Transfusion; 2013 Jul; 53(7):1405-15. PubMed ID: 23362802 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors. Challine D; Chevaliez S; Pawlotsky JM Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]